215 related articles for article (PubMed ID: 16522345)
1. Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.
de Avila Botton S; Brum MC; Bautista E; Koster M; Weiblen R; Golde WT; Grubman MJ
Vaccine; 2006 Apr; 24(17):3446-56. PubMed ID: 16522345
[TBL] [Abstract][Full Text] [Related]
2. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
[TBL] [Abstract][Full Text] [Related]
3. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z
Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848
[TBL] [Abstract][Full Text] [Related]
4. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine.
Pena L; Moraes MP; Koster M; Burrage T; Pacheco JM; Segundo FD; Grubman MJ
Vaccine; 2008 Oct; 26(45):5689-99. PubMed ID: 18762225
[TBL] [Abstract][Full Text] [Related]
5. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
[TBL] [Abstract][Full Text] [Related]
6. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.
Du Y; Li Y; He H; Qi J; Jiang W; Wang X; Tang B; Cao J; Wang X; Jiang P
J Virol Methods; 2008 Apr; 149(1):144-52. PubMed ID: 18294705
[TBL] [Abstract][Full Text] [Related]
7. Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18.
Ma M; Jin N; Shen G; Zhu G; Liu HJ; Zheng M; Lu H; Huo X; Jin M; Yin G; Ma H; Li X; Ji Y; Jin K
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):1-7. PubMed ID: 17706296
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.
Moraes MP; de Los Santos T; Koster M; Turecek T; Wang H; Andreyev VG; Grubman MJ
J Virol; 2007 Jul; 81(13):7124-35. PubMed ID: 17459931
[TBL] [Abstract][Full Text] [Related]
9. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
10. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.
Moraes MP; Chinsangaram J; Brum MC; Grubman MJ
Vaccine; 2003 Dec; 22(2):268-79. PubMed ID: 14615155
[TBL] [Abstract][Full Text] [Related]
11. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
Li X; Liu R; Tang H; Jin M; Chen H; Qian P
Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
[TBL] [Abstract][Full Text] [Related]
12. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
[TBL] [Abstract][Full Text] [Related]
13. Engineering better vaccines for foot-and-mouth disease.
Mason PW; Chinsangaram J; Moraes MP; Mayr GA; Grubman MJ
Dev Biol (Basel); 2003; 114():79-88. PubMed ID: 14677679
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18.
Mingxiao M; Ningyi J; Juan LH; Min Z; Guoshun S; Guangze Z; Huijun L; Xiaowei H; Minglan J; Xu L; Haili M; Yue J; Gefen Y; Kuoshi J
Antiviral Res; 2007 Oct; 76(1):59-67. PubMed ID: 17606304
[TBL] [Abstract][Full Text] [Related]
15. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine.
Pacheco JM; Brum MC; Moraes MP; Golde WT; Grubman MJ
Virology; 2005 Jul; 337(2):205-9. PubMed ID: 15893355
[TBL] [Abstract][Full Text] [Related]
16. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
Medina GN; Montiel N; Diaz-San Segundo F; Sturza D; Ramirez-Medina E; Grubman MJ; de los Santos T
Clin Vaccine Immunol; 2015 Nov; 23(2):125-36. PubMed ID: 26607309
[TBL] [Abstract][Full Text] [Related]
18. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
19. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
Qian P; Li XM; Jin ML; Peng GQ; Chen HC
Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
[TBL] [Abstract][Full Text] [Related]
20. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
Schutta C; Barrera J; Pisano M; Zsak L; Grubman MJ; Mayr GA; Moraes MP; Kamicker BJ; Brake DA; Ettyreddy D; Brough DE; Butman BT; Neilan JG
Vaccine; 2016 Jun; 34(27):3214-3220. PubMed ID: 26707216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]